BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 21169446)

  • 21. Structural and biochemical characterization of the protease domain of the mosaic botulinum neurotoxin type HA.
    Lam KH; Sikorra S; Weisemann J; Maatsch H; Perry K; Rummel A; Binz T; Jin R
    Pathog Dis; 2018 Jun; 76(4):. PubMed ID: 29688327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arrangement of the Clostridium baratii F7 toxin gene cluster with identification of a σ factor that recognizes the botulinum toxin gene cluster promoters.
    Dover N; Barash JR; Burke JN; Hill KK; Detter JC; Arnon SS
    PLoS One; 2014; 9(5):e97983. PubMed ID: 24853378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluorigenic substrates for the protease activities of botulinum neurotoxins, serotypes A, B, and F.
    Schmidt JJ; Stafford RG
    Appl Environ Microbiol; 2003 Jan; 69(1):297-303. PubMed ID: 12514008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unique substrate recognition by botulinum neurotoxins serotypes A and E.
    Chen S; Barbieri JT
    J Biol Chem; 2006 Apr; 281(16):10906-11. PubMed ID: 16478727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombination and insertion events involving the botulinum neurotoxin complex genes in Clostridium botulinum types A, B, E and F and Clostridium butyricum type E strains.
    Hill KK; Xie G; Foley BT; Smith TJ; Munk AC; Bruce D; Smith LA; Brettin TS; Detter JC
    BMC Biol; 2009 Oct; 7():66. PubMed ID: 19804621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a fusion protein SNVP as substrate for assaying multi-serotype botulinum neurotoxins.
    Luo S; Li T; Wang Q; Tian R; Liu H; Fang H; Chen F; Wang H
    Anal Biochem; 2014 Oct; 463():75-81. PubMed ID: 23851341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved detection of botulinum neurotoxin serotype A by Endopep-MS through peptide substrate modification.
    Wang D; Baudys J; Ye Y; Rees JC; Barr JR; Pirkle JL; Kalb SR
    Anal Biochem; 2013 Jan; 432(2):115-23. PubMed ID: 23017875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimization of peptide substrates for botulinum neurotoxin E improves detection sensitivity in the Endopep-MS assay.
    Wang D; Krilich J; Baudys J; Barr JR; Kalb SR
    Anal Biochem; 2015 Jan; 468():15-21. PubMed ID: 25232998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Comprehensive Structural Analysis of
    Gregory KS; Acharya KR
    Toxins (Basel); 2023 Jan; 15(2):. PubMed ID: 36828407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tetanus and botulinum neurotoxins: turning bad guys into good by research.
    Rossetto O; Seveso M; Caccin P; Schiavo G; Montecucco C
    Toxicon; 2001 Jan; 39(1):27-41. PubMed ID: 10936621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A yeast assay probes the interaction between botulinum neurotoxin serotype B and its SNARE substrate.
    Fang H; Luo W; Henkel J; Barbieri J; Green N
    Proc Natl Acad Sci U S A; 2006 May; 103(18):6958-63. PubMed ID: 16636286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Production of an expression system for a synaptobrevin fragment to monitor cleavage by botulinum neurotoxin B.
    Nowakowski JL; Courtney BC; Bing QA; Adler M
    J Protein Chem; 1998 Jul; 17(5):453-62. PubMed ID: 9717740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of substrate recognition by the novel Botulinum Neurotoxin subtype F5.
    Guo J; Chan EW; Chen S
    Sci Rep; 2016 Jan; 6():19875. PubMed ID: 26794648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synaptic vesicle chips to assay botulinum neurotoxins.
    Ferracci G; Miquelis R; Kozaki S; Seagar M; Lévêque C
    Biochem J; 2005 Nov; 391(Pt 3):659-66. PubMed ID: 16011482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative characterization of botulinum neurotoxin subtypes F1 and F7 featuring differential substrate recognition and cleavage mechanisms.
    Guo J; Chan EW; Chen S
    Toxicon; 2016 Mar; 111():77-85. PubMed ID: 26748154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Substrate recognition of VAMP-2 by botulinum neurotoxin B and tetanus neurotoxin.
    Chen S; Hall C; Barbieri JT
    J Biol Chem; 2008 Jul; 283(30):21153-9. PubMed ID: 18511417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimization of SNAP-25 and VAMP-2 Cleavage by Botulinum Neurotoxin Serotypes A-F Employing Taguchi Design-of-Experiments.
    von Berg L; Stern D; Weisemann J; Rummel A; Dorner MB; Dorner BG
    Toxins (Basel); 2019 Oct; 11(10):. PubMed ID: 31614566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clostridium botulinum and botulinum neurotoxin].
    Hirai Y
    Brain Nerve; 2011 Jul; 63(7):755-61. PubMed ID: 21747146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mass Spectrometric Detection of Bacterial Protein Toxins and Their Enzymatic Activity.
    Kalb SR; Boyer AE; Barr JR
    Toxins (Basel); 2015 Aug; 7(9):3497-511. PubMed ID: 26404376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A label-free biosensor assay for botulinum neurotoxin B in food and human serum.
    Ferracci G; Marconi S; Mazuet C; Jover E; Blanchard MP; Seagar M; Popoff M; Lévêque C
    Anal Biochem; 2011 Mar; 410(2):281-8. PubMed ID: 21134347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.